Ribomic Completes Enrollment For Umedaptanib Pegol Achondroplasia Study
03 Aug 2024 //
BUSINESSWIRE
RIBOMIC Phase I and II Data Published in the Eye
05 Dec 2023 //
BUSINESSWIRE
RIBOMIC Completes IND Submission for Phase 2 Trial of RBM-007 in Achondroplasia
19 Apr 2022 //
BUSINESSWIRE
RIBOMIC Provides Update on RBM-007 Program in wAMD
23 Mar 2022 //
BUSINESSWIRE
RIBOMIC Announces Preliminary Topline Data From Phase 2 Trials of RBM-007
29 Dec 2021 //
BUSINESSWIRE
Ribomic`s RBM-007 fails to meet primary endpoints in Phase 2 study
29 Dec 2021 //
TRIALSITENEWS
RIBOMIC Announces RBM-007 Phase 1 Clinical Trial Results
15 Nov 2021 //
BUSINESSWIRE
RIBOMIC Announces Masked Preliminary Interim Data from Phase 2 Trials of RBM-007
30 Sep 2021 //
BUSINESSWIRE